www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Escherichia coli

 

 

Read the Chapter

Sliding Table of Contents on the left of the screen

 

Vignettes

Review Article: Cennimo DJ, Koo H, Mohamed JA, Huang DB, Chiang T.  Enteroaggregative Escherichia coli: A Review of Trends, Diagnosis, and Treatment.  Infect in Med 2007;24:100-110.

Review Article:  Pitout JD. Enterobacteriaceae Producing ESBLs in the Community: Are They a Real Threat?  Infect Med 2007;24:57-65.

Review Article:  Efflux Pumps as a Mechanism of Antimicrobial Resistance. 2008

Review Article:  Bush K, et al.  MiniReview: Updated Functional Classification of β-lactamases.  Antimicrob Agents Chemother 2010;54:969-976.

Butler T. Loperamide for the Treatment of Traveler's Diarrhea: Broad or Narrow Usefulness? Clin Infect Dis 2008; 47:1015-6

Shulman ST, Friedmann HC, Sims RH.  Theodor Escherich: The First Pediatric Infectious Diseases Physician? Clin Infect Dis 2005;45:1025-1029.

Dixon B.  Disseminators Aloft?  Microbe 2007;2:416-417.

Falagas ME, Kastoris AC, et al. Fosfomycin for the Treatment of Multidrug-Resistant, Including Extended-Spectrum beta-Lactamase Producing, Enterobacteriaceae Infections: A Systematic Review. Lancet Infect Dis. 2010 Jan;10:43-50.

Golnaz J, Zuravleff J.  Retinitis and Endophthalmitis. 2007.

Ternhag A, Torner A, et al.  Short- and Long-term Effects of Bacterial Gastrointestinal Infections. Emerg Infect Dis 2008;14:143-148.

Talan DA, et al. Prevalence and Risk Factor Analysis of Trimethoprim-Sulfamethoxazole and Fluoroquinolone-Resistant Escherichia coli Infection among Emergency Department Patients with Pyelonephritis. Clinical Infectious Diseases 2008;47:1150–1158.

Auer S, et al. Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Causes by Extended-Spectrum-β-Lactamase-Producing Escherichia coli.  Antimicrob Agents Chemother 2010;54:4006-4008.

 

Tables and Figures

Table 1: Serogroup Clustering of Different Types of E. coli Infections.

Table 2: In Vitro Susceptibility of Escherichia coli to Antimicrobials

Table 3: Antimicrobial Resistance Among Enteropathogenic E. coli Strains. 

Table 4: Antibiotic Resistance In Community-Acquired Urinary Tract Infections Due To E. coli

Table 5a: Treatment Options for E. coli Urinary Tract Infections 

Table 5b: Oral and Parenteral Regimens for E. coli Urinary Tract Infections

 

Authors

Allen C. Cheng, MB, BS, FRACP Nathan M. Thielman, M.D., MPH Richard L. Guerrant, M.D.

 

 

 

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]